2nd Line Treatment Options Following 1st Line PD-L1 Targeting Agents

Martin E. Gutierrez, MD Director, Phase I Program, Co-Chair of Thoracic Oncology, John Theurer Cancer Center and Hackensack Meridian Health explains his take on how he would treat 1nd line patients wh... Author: obr Added: 06/27/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts